Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
3.270
+0.060 (1.87%)
Nov 5, 2024, 3:43 PM EST - Market open

Phio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
32514166
Upgrade
Market Cap Growth
-36.32%-63.48%-62.43%-12.96%146.99%5.09%
Upgrade
Enterprise Value
-2-6-9-13-1-2
Upgrade
Last Close Price
3.216.8440.18108.00290.521015.74
Upgrade
PE Ratio
--0.15-0.44-0.97-1.40-
Upgrade
PS Ratio
-----299.79
Upgrade
PB Ratio
0.430.240.470.621.191.10
Upgrade
P/FCF Ratio
-0.35-0.17-0.42-1.14-1.76-0.72
Upgrade
P/OCF Ratio
-0.35-0.17-0.42-1.14-1.77-0.73
Upgrade
EV/Sales Ratio
------89.12
Upgrade
EV/EBITDA Ratio
0.380.610.810.940.070.21
Upgrade
EV/EBIT Ratio
0.380.610.800.940.070.21
Upgrade
EV/FCF Ratio
0.360.600.751.060.070.21
Upgrade
Debt / Equity Ratio
-0.000.020.010.050.09
Upgrade
Debt / FCF Ratio
-0.00-0.01-0.02-0.07-0.06
Upgrade
Asset Turnover
-----0.00
Upgrade
Quick Ratio
3.085.206.087.846.493.69
Upgrade
Current Ratio
3.475.716.428.066.913.88
Upgrade
Return on Equity (ROE)
-126.86%-116.60%-70.06%-76.04%-93.73%-92.19%
Upgrade
Return on Assets (ROA)
-61.06%-59.86%-37.72%-41.28%-46.22%-48.09%
Upgrade
Return on Capital (ROIC)
-77.95%-70.71%-43.11%-47.06%-55.16%-56.61%
Upgrade
Earnings Yield
-313.98%-582.98%-225.79%-98.17%-56.55%-141.50%
Upgrade
FCF Yield
-327.84%-579.10%-240.93%-87.99%-56.73%-138.46%
Upgrade
Buyback Yield / Dilution
-184.03%-83.32%-6.30%-179.70%--
Upgrade
Total Shareholder Return
-184.03%-83.32%-6.30%-179.70%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.